A detailed history of Berger Financial Group, Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Berger Financial Group, Inc holds 14,029 shares of ABBV stock, worth $2.39 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
14,029
Previous 5,940 136.18%
Holding current value
$2.39 Million
Previous $1.02 Million 172.1%
% of portfolio
0.24%
Previous 0.09%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $1.33 Million - $1.61 Million
8,089 Added 136.18%
14,029 $2.77 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $52,009 - $60,735
336 Added 6.0%
5,940 $1.02 Million
Q1 2024

Apr 16, 2024

BUY
$159.82 - $182.1 $37,397 - $42,611
234 Added 4.36%
5,604 $1.02 Million
Q4 2023

Feb 07, 2024

SELL
$137.6 - $154.97 $13,897 - $15,651
-101 Reduced 1.85%
5,370 $832,000
Q3 2023

Nov 03, 2023

SELL
$133.59 - $154.65 $37,672 - $43,611
-282 Reduced 4.9%
5,471 $815,000
Q2 2023

Aug 10, 2023

BUY
$132.51 - $164.9 $1,855 - $2,308
14 Added 0.24%
5,753 $775,000
Q1 2023

Apr 24, 2023

BUY
$144.61 - $166.54 $64,929 - $74,776
449 Added 8.49%
5,739 $914,000
Q4 2022

Jan 30, 2023

BUY
$138.31 - $165.87 $119,361 - $143,145
863 Added 19.49%
5,290 $855,000
Q3 2022

Oct 27, 2022

BUY
$134.21 - $153.93 $40,128 - $46,025
299 Added 7.24%
4,427 $594,000
Q2 2022

Aug 08, 2022

BUY
$137.62 - $174.96 $13,624 - $17,321
99 Added 2.46%
4,128 $632,000
Q1 2022

May 10, 2022

BUY
$131.98 - $163.75 $6,335 - $7,860
48 Added 1.21%
4,029 $653,000
Q4 2021

Jan 26, 2022

BUY
$107.43 - $135.93 $90,456 - $114,453
842 Added 26.82%
3,981 $539,000
Q3 2021

Oct 28, 2021

BUY
$106.4 - $120.78 $106 - $120
1 Added 0.03%
3,139 $339,000
Q2 2021

Jul 29, 2021

SELL
$105.21 - $117.21 $19,884 - $22,152
-189 Reduced 5.68%
3,138 $354,000
Q1 2021

May 12, 2021

SELL
$102.3 - $112.62 $15,345 - $16,893
-150 Reduced 4.31%
3,327 $360,000
Q4 2020

Feb 02, 2021

BUY
$80.49 - $108.67 $279,863 - $377,845
3,477 New
3,477 $373,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Berger Financial Group, Inc Portfolio

Follow Berger Financial Group, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berger Financial Group, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Berger Financial Group, Inc with notifications on news.